Contacting James Love Work phone: +1.202.332.2670 | Mobile Phone +1.202.361.3040 | Email: james.love@keionline.org Twitter: @jamie_love Blue Sky: @jamielove@bsky.social Fediverse: @jameslove@hackyderm.io (Give my office a call or give me another nudge if you have difficulty getting a response. I am overwhelmed… Continue Reading
Knowledge Ecology International (KEI) is a not for profit non governmental organization that searches for better outcomes, including new solutions, to the management of knowledge resources. KEI is focused on social justice, particularly for the most vulnerable populations, including low-income… Continue Reading
KEI is a U.S. tax exempt organization, under 501(3)(c) of the IRS rules. In 2006 KEI received a MacArthur Award for Creative and Effective Institutions. MacArthur Award KEI Acceptance Remarks KEI receives contributions from individuals, by check, or through the… Continue Reading
Sakiko Fukuda-Parr, Chair Sakiko Fukuda-Parr is a Professor of International Affairs at The New School, New York. A development economist, her current work focuses on global policies for human development and human rights in diverse areas including poverty reduction, conflict… Continue Reading
KEI is a U.S. tax exempt organization, under 501(3)(c) of the IRS rules. KEI is supported by grants and research contracts, including in recent years from the following institutions: Foundation to Promote Open Society Perls Foundation Kaiser Foundation Health Plan… Continue Reading
On January 15, 2018, PhRMA provided comments on the Colombian Resolution 5246, a public interest declaration for several drugs for the hepatitis c virus (HCV). A copy of the PhRMA letter is attached below. It is a combination of complaints… Continue Reading
In November 2017, the World Health Organization (WHO) published a report charting a path forward for the expansion of WHO’s work on the transparency of R&D costs and medicines prices while rekindling the prospects for WHO to assume the mantle of… Continue Reading
The Cámara de Diputados of the Chilean Congress has overwhelmingly passed a resolution calling on the President to advance the compulsory licensing request on HCV drugs made in March 2017 by patients, advocates including Innovarte NGO, and elected officials. The resolution, Number… Continue Reading
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On November 29, 2017, the National Institutes of Health (NIH) has given a notice to a prospective license to patents on the treatment of renal cell carcinoma,… Continue Reading
On Friday afternoon, 15 December 2017, the 27th session of the WIPO Standing Committee on the Law of Patents (SCP) agreed to a future program of work that included the following topics: 1) Exceptions and Limitations to Patent Rights, 2)… Continue Reading